Clinical central laboratory services
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N93021D00021
- Awardee
-
Cerba Research Usa, Inc. UEI W15NDJ1DSXN9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $2,144,986 obligated
Award facts
- Opportunity
-
- Clinical central laboratory services Pre-Solicitation · 75N93021D00021 · Posted Jan 8, 2020
- Clinical central laboratory services Award Notice · Posted May 5, 2021
- Combined order value
- $2,144,986 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 43% used
- $4,975,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite-delivery contract to Cerba Research USA, Inc. with a ceiling of $4,975,000 on May 13, 2021, with an ultimate completion date of May 12, 2026.
The contract procures clinical central laboratory services to support NIAID's vaccine and therapeutic clinical trials program. Performance occurs at Cerba Research's facility in New Hyde Park, New York. The contract carries a five-year period of performance from award through the May 2026 completion date.
Two delivery orders have been issued under this IDIQ. A September 2023 firm fixed-price delivery order valued at $529,892 funded clinical central laboratory services for three NIAID infectious disease protocols (23-0005, 22-0011, 23-0006) through September 30, 2025. An earlier April 2022 firm fixed-price delivery order worth $1,382,498.14 (ceiling $1,615,094.14) provided SARS-CoV-2 testing support through December 31, 2023, split across two funding CAN lines.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$25,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $25,000 |
Quick answers
Who was awarded contract 75N93021D00021?
75N93021D00021 was awarded to Cerba Research Usa, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 13, 2021.
How much is contract 75N93021D00021 worth?
Orders under 75N93021D00021 have obligated $2,144,986. 75N93021D00021's own ceiling is $4,975,000.
How many orders have been placed under contract 75N93021D00021?
2 orders have been placed under 75N93021D00021, the latest on September 18, 2023.
Who can order from contract 75N93021D00021?
75N93021D00021 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93021D00021 competed?
The extent of competition for 75N93021D00021 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV